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Germ-line transmission of trisomy 21: Data from
80 families suggest an implication of




Background: Trisomy of chromosome 21 (T21; Down syndrome, DS) is the most common aneuploidy in live
births. Though its etiology has been intensively studied for a half of century, there are surprisingly many problems
awaiting their elucidation. Some of the open questions are related directly to germ line mosaicism for T21, other
problems include the prevalence of males with non-mosaic trisomy over females (skewed sex ratio, SR), the genetic
predisposition to non-disjunction, etc. Studies in families of gonadal mosaicism (GM) carriers might help resolving
some of these problems.
Results: 80 families of carriers of GM, in which the sex of the offspring had been specified, were identified in the
literature and in logbooks of two local genetic units. Mothers in these families were relatively young: only 8% of
mothers were 35 years old and older at the time of delivery of their first affected offspring while the proportion of
grandmothers on the GM carrier’s side aged 35 years old and older was significantly higher (39%). Postzygotic
rescue of T21 due to error in the meiosis I had been proposed as a mechanism of parental GM formation in 78%
of the families with known origin of the T21. For the other 22%, rescue of errors in the meiosis II or postzygotic
mitotic non-disjunction was assumed. Mosaicism for T21 in successive generations was reported in at least 12
families. The proportion of mosaics among affected female offspring (14%) is significantly higher compared to that
among affected male offspring (0%). Male preponderance (SR = 1.5) is found in non mosaic liveborn offspring with
either maternally- or paternally transmitted T21. Among unaffected offspring of male carriers of GM there is a
notable excess of females (SR = 0.27).
Conclusion: Both direct (results of cytogenetic and molecular study of the origin of trisomic line) and indirect
(advanced grandmaternal age on the side of GM carrier) evidences allow to assume that significant proportion of
the mosaic parents had been conceived as trisomics. Female-specific trisomy rescue and genetic predisposition to
postzygotic non-disjunction has been suggested as mechanisms of formation of both GM and somatic mosaicism.
Typical male preponderance in affected non mosaic offspring with either maternally- or paternally transmitted
trisomy 21, indicates than meiotic events are not responsible for the skewed sex ratio in DS. However a female
excess among unaffected offspring of male carriers of GM might be the result of meiotic non homologous co-
orientation of chromosomes 21 and X in spermatogenesis.
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Introduction
Trisomy of chromosome 21 (T21; Down syndrome, DS)
is the most common aneuploidy in livebirths [1].
Though its etiology has been intensively studied for
almost half a century, there are surprisingly many pro-
blems awaiting their elucidation [2]. Some of the open
questions are related directly to germ line mosaicism
(including precise evaluation the contribution of paren-
tal mosaicism to the occurrence of DS cases, the timing
of mosaicism formation and the underlying mechan-
isms) [3,4]. Other problems are the genetic predisposi-
tion to non-disjunction (NDJ) [5], the effect of
endogenous factors and environmental exposures, the
prevalence of males with non-mosaic trisomy over
females [6]. Studies in families of gonadal mosaicism
(GM) carriers might help to resolve some of these
problems.
Non-mosaic free T21 is mostly a result of NDJ in
oogenesis. The majority of maternally derived trisomies
occur in meiosis I, meiosis II errors only constitute
about 20% of maternal errors. Paternally derived triso-
mies are several times less frequent and display about
an equal number of errors in meiosis I and meiosis II.
In about 4% of trisomic individuals, the additional chro-
mosome appears to result from postzygotic error [7]. In
a collective sample of 53 affected individuals with
mosaic T21, somewhat different proportions were
found, with a higher contribution of paternally derived
extra chromosome (24%) and a higher rate (42%) of
NDJ in meiosis II and mitotic NDJ in a normal euploid
zygote [8]. Whether the contribution of different
mechanisms to the formation of a trisomic line in
asymptomatic GM carriers is different from that in
affected individuals is still to be investigated.
There are few widely cited reports of mosaicism for
T21 in two successive generations in one family [9-11]
suggesting genetic predisposition to NDJ. Large samples
are needed to confirm a genetic predisposition and to
shed light on the underlying mechanism.
A study on the male to female ratio (sex ratio, SR) in
individuals with maternally transmitted T21 might help
to elucidate the phenomenon of the male prevalence
among patients with DS. Male excess in DS patients
with non-mosaic T21 is a well known but poorly under-
stood phenomenon. The sex ratio varies in different
populations, being close to average 1.3. Several hypoth-
eses have been put forward to explain the skewed SR in
DS. Meiotic disturbance (non-homologous co-orienta-
tion in male meiosis) [12,13], fertilization event (greater
accessibility of Y-bearing sperm to ova disomic for chro-
mosome 21 or promotion of non-disjunction in the ova
by Y-bearing sperm) [14-16], and post-fertilization
events (intrauterine selection against females) [17,18]
have been discussed. Since females produce only
X-bearing gametes, an approach to the problem may be
the comparison of SR in cases of maternal and paternal
transmission of T21.
Some earliest publications suggested that the risk for
Down syndrome may be related to an aging grand-
mother [19,20]. Since then, not many studies on paren-
tal and gradparental ages in families of carriers of GM
were reported. As expected, mean maternal age at birth
of their DS children was found to be similar to that at
the birth of a normal baby. However, the mean grand-
maternal age at the birth of the mosaic parents was sig-
nificantly higher than that at the birth of trisomic DS
[21-23]. These studies supported a suggestion that most
or all mosaic parents arose from trisomic zygotes [20].
To confirm this suggestion, more data on association of
grandparental ages and grandparental origin of the
mosaicism are needed.
The objectives of this study were: (1) to estimate the
contribution of different mechanisms to the origin of
germ line mosaicism; (2) to determine the prevalence of
“inherited” mosaicism; (3) to study the sex ratio in
affected offspring with respect to the mode of ascertain-
ment and the parent of origin; (4) to study the sex ratio
in unaffected offspring; and (5) to study maternal and
grandmaternal ages in families of carriers of gonadal
nosaicism.
Results
Families with maternal trisomy 21 gonadal mosaicism
Table S1 (see Additional file 1: Details of families with
maternal trisomy 21 gonadal mosaicism) presents the
data collected from reports on parental GM for T21. In
total, 61 families were identified where the mother was
a carrier of germ mosaicism, with 114 affected offspring
for whom the sex was specified. Among the affected off-
spring, there were 50 males and 34 females (SR = 1.5)
postnatally diagnosed as DS (including six patients with
clinical diagnosis), 13 male and 12 female fetuses with
prenatally diagnosed trisomy 21 (SR = 1.08), and 2 male
and 3 female miscarried fetuses with T21. Six in 108
affected individuals/fetuses with confirmed T21 (5.6%)
were found to be mosaic for a normal cell line. All of
them were females. Among unaffected siblings, there
were 19 males and 16 females.
In about half of the cases, maternal GM was inferred
from the presence of a trisomic line in a single somatic
tissue. In 15 cases, mosaicism found in blood cells was
confirmed in cultured skin fibroblasts. In eight
instances, a trisomic line was detected in an ovarian tis-
sue, and in one case it was found in oocytes. In one
remarkable case, maternal mosaicism was identified
because of maternal cell contamination of an amniotic
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fluid specimen from a normal male pregnancy (Addi-
tional File 1: Table S1, case 53). In six cases, GM was
uncovered by DNA analysis. Maternal origin of T21 in
the affected offspring was proven in 15 families. In the
majority of the informative cases (9/11), the study
results were consistent with the original trisomy in the
mother due to NDJ in first meiotic division followed by
loss of one chromosome 21 (rescue of trisomy MI, for
simplicity) as a mechanism of formation of germ-line
mosaicism. In two families, the study results suggested
that the origin of maternal mosaicism was either postzy-
gotic mitotic or second meiotic division NDJ (rescue of
trisomy MII). And in two families, the origin of mater-
nal mosaicism was not clarified. In two nuclear families
from the same pedigree (Additional File 1: Table S1,
cases 2, 3) and in two other cases (Additional File 1:
Table S1, cases 7, 61) the trisomy in the carriers was
most probably inherited (rescue of transmitted trisomy).
Information on the maternal age at the time of deliv-
ery of their first affected offspring was available for 54
families. Two cases from surveys on prevalence of
mosaicism in young parents (Additional File 1: Table
S1, cases 14, 34) were excluded from the analysis of
maternal age. The great majority of the mothers were
young at the time of conception/delivery of their first
affected offspring, the proportion of mothers aged 35
year and older was 3 out of 52 (5.8%).
Families with paternal trisomy 21 gonadal mosaicism
Among 28 offspring in 19 families where the father was
reported to be a carrier of T21 mosaicism (Additional
File 2: Table S2, Details of families with paternal trisomy
21 gonadal mosaicism), there were 16 males and 10
females with postnatally diagnosed T21 (including one
patient with clinical diagnosis), one prenatally detected
female fetus, and one miscarried female fetus. Three out
of 27 cytogenetically confirmed T21 cases displayed
mosaicism for a normal cell line, two of them were
females and one was non-DS male child with xeroderma
pigmentosum. Three male and 11 female siblings were
either normal or diagnosed as non-DS (SR = 0.27).
In the majority of the cases, paternal GM was inferred
from the presence of trisomic cells in cultured blood
cells. In two cases, mosaicism was detected in other tis-
sue(s). A paternal origin of the extra chromosome 21 in
the trisomic offspring was confirmed in four families,
indicating a probable trisomy MI rescue in two carriers
of GM and probable MII NDJ or postzygotic mitotic
origin in one carrier; and in one case molecular analysis
failed to define the mechanism resulting in T21 cell line.
Information on the maternal age at the time of deliv-
ery of their first affected offspring was available for 16
families. However three cases from a survey on preva-
lence of mosaicism in young parents (Additional File 2:
Table S2, cases 3 - 5) were excluded from the analysis
of maternal age. In this group, two in 13 mothers were
aged 35 years and older.
Total sample (all families with either maternal or paternal
trisomy 21 gonadal mosaicism)
Overall, there were 61 families with maternal GM for
T21 and 19 families with paternal GM for T21, indicat-
ing a strong female prevalence among carriers of GM.
Among 80 families, there were reported 12 families
showing mosaicism for T21 in successive generations.
They included seven families with eight affected/miscar-
ried carriers (Additional File 1: Table S1, cases 5, 26, 43,
46, 51, and Additional File 2: Table S2, cases 16 and
19), a family with one mosaic non-DS child (Additional
File 2: Table S2, case 1), and four families with asympto-
matic carriers of GM (Additional File 1: Table S1, cases
2, 3, 7, 61).
Among apparently transmitted cases of T21, there
were more males than females among postnatally diag-
nosed individuals (66 M/44 F, SR = 1.5), no significant
male prevalence among prenatally diagnosed cases
(13 M/12 F, SR = 1.08) and female excess among
miscarried fetuses (2 M/4 F, SR = 0.5). However,
because of the limited sample, the difference does not
reach statistical significance.
Nine of 134 (6.7%) individuals with confirmed T21
were mosaics for a normal cell line. In this group, there
were one male with no clinical features of DS (Addi-
tional File 2: Table S2, case 1) and eight affected females
(Additional File 1: Table S1, cases 5, 26, 43, 46, 51, and
Additional File 2: Table S2, cases 16 and 19). The male
to female ratio in this group is different from both the
SR = 1.06 in the general population and from SR = 1.3
typical for T21 patients (p = 0.0158 and p = 0.0071,
respectively). Therefore, the proportion of mosaics
among affected females (8/59 = 14%) differs significantly
from 0, the proportion found among 76 affected males
(p = 0.005).
Of 14 families where the origin of the T21 in the GM
carrier was traced, trisomy MI rescue was suggested as a
mechanism of formation of parental GM in 78% (11/14).
Rescue of trisomy MII or postzygotic mitotic origin
were suggested in three cases. In four families with
mosaicism in successive generations, the T21 in the car-
rier was most probably the result of the rescue of trans-
mitted trisomy.
Mothers were young in either parental group, and
mean maternal age in the combined group was 26.4 yr,
with proportion of mothers aged 35 years and older
being 5/65 = 8%. There were 51 families for which a
sufficient reproductive history and pregnancy outcome
were known. In 17 of these families, the first born DS
child/fetus was not the first born child/fetus (Additional
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File 1: Table S1, cases 8, 10, 18, 20, 25, 27, 36, 38, 49,
51, 53, 59, 61, and Additional File 2: Table S2, cases 8,
9, 11, 14). In this group, the proportion of mothers aged
35 years and older at the time of DS birth was 6%,
and mean maternal age was 28.4 yr. The analysis of
grandmaternal age, however, showed a large proportion
(9/23 = 39%) of them aged 35 yr and older at the time
of the birth of their GM offspring.
Discussion
Mechanisms of germ mosaicism formation
Two different mechanisms are responsible for the for-
mation of mosaicism. One is a mitotic error in a nor-
mal, euploid zygote resulting in a mosaic embryo having
46/47,+21 karyotype, the 45,-21 cell line being nonvi-
able. Recently, it was demonstrated that mitotic errors
of chromosome 21 are associated with non-viability of
preimplantation embryo [24]. This most likely can be
explained by the presence of nonvialble monosomic line.
According to data on assessment mosaicism in human
IVF embryo, > 3/8 of abnormal/removed blastomeres is
considered detrimental for embryo survival [25].
The other mechanism is a NDJ in parental gametogen-
esis followed by an early postzygotic malsegregation of
chromosome 21 ("trisomy rescue”). There are two
mechanisms of chromosome malsegregation in a trisomic
conceptus, chromosome loss and NDJ, the latter resulting
in a mosaic embryo with a 46/47,+21/48,+21,+21 karyo-
type. In vitro studies in binucleated lymphocytes of tris-
omy 21 patients and of healthy children showed that the
frequency of NDJ was significantly higher than the loss of
chromosome 21. Moreover, malsegregation of chromo-
some 21 occurs more often in trisomic 21 cells than in
disomic cells from normal children [26]. Although very
rarely, some few cases of mosaicism for a tetrasomic line
were found in prenatal samples [27].
It was suggested that the presence of a tetrasomic line
in the gonads of a carrier of GM mosaicism might
explain some cases of extraordinary occurrence of sev-
eral conceptions of trisomy 21 in a one sibship [28-31].
It should be noted though, that no tetrasomic cells were
reported in published studies on ovaries of carriers of
GM [9,28,32-36]. Another underlying mechanism of a
high recurrence of trisomic offspring in some families
was proposed recently [4]. This mechanism suggests a
specific type of secondary non-disjunction in a T21
oocyte by formation of either a trivalent or a bivalent
plus univalent.
As stated in the recent review on somatic genome var-
iation that addresses mosaic aneuploidy generation
mechanisms [37], any disturbance occurring at molecu-
lar, supramolecular or intercellular level, can be asso-
ciated with mitotic NDJ or other types of mitotic errors
leading to aneuploidy. Among the most common causes
of chromosome missegregation, different defects in kine-
tochore apparatus are suggested. Of them, merotelic
kinetochore-microtubule attachment is considered as
one of the commonest mechanism [37].
Up to now, there was lack of sufficient information on
parental and cell division origin of trisomic line in
asymptomatic GM carriers. Based on an estimation
from maternal ages of the normal, mosaic and nonmo-
saic trisomic individuals, Richards [22] proposed that
unlike mosaic DS, a large proportion of asymptomatic
mosaic carriers started as normal zygotes. Since then,
no studied were conducted for testing this hypothesis.
In the present study, the majority of the mosaic parents
were found to be a product of trisomic zygotes.
Mosaicism transmission or genetic predisposition to
nondisjunction
Surprisingly, the data collected give evidence for a high
frequency of mosaic 46/47,+21 offspring in carriers of
GM. In 80 studied families, seven families with eight
affected mosaic females were identified. There is no
appropriate explanation for the high prevalence of
mosaic females among affected offspring of GM carriers.
Both genetic predisposition to NDJ [11] and sex-specific
rescue due to either sex-specific chromosome loss [38]
or sex-specific selection against abnormal cell line [39]
can be suggested.
Mosaicism for a normal line is not frequently found
either in postnatally or in prenatally detected trisomics,
accounting for only 1-3% of all free T21 cases
[17,18,40]. In contrast to a significant male excess typi-
cal to DS individuals with non-mosaic T21 (SR~1.3), a
notable female prevalence was reported for carriers of
mosaicism, being higher in prenatally detected cases
(SR = 0.6) than in newborns (SR = 0.95) [17,18,40].
Therefore, both the high frequency of the “inherited”
mosaicism and the strong female prevalence among
mosaic offspring of carriers of germ-line mosaicism
found in the present study were not expected.
Five cases of unaffected carriers of mosaicism for T21
in two successive generations were also reported, includ-
ing two families with asymptomatic mosaicism “inher-
ited” by a healthy GM carrier [10,41], one family with
non-DS mosaic child with xeroderma pigmentosum
[11], and two nuclear families from a pedigree with
recurrent T21 where several healthy family members
were found to have uniparental disomy (UPD) of chro-
mosome 21 [42]. The latter most probably indicates pre-
sence of GM in three generations, in the mother of two
fetuses with T21 (case II/2), in her father (case III/1)
and in his sister (case I/2), and in one of her paternal
grandparents. Additionally, in some families where
the individuals with T21 were second-degree and third-
degree relatives, undetected GM could not be excluded
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[43]. One may suggest that the trisomic fetus in the
family RDS-15 from the same study, who was identified
as a product of meiosis II/mitotic NDJ of a paternal
chromosome (bbd), inherited two chromosomes from
his mosaic (bc/bbc) father, who in turn had inherited a
trisomy from his mosaic mother (ab/abb), who also had
given birth to twins with trisomy (abc). In the family
RDS-19, the parents in whom NDJ in maternal meiosis I
and in paternal meiosis II was identified were siblings.
In this case, one may assume a grandmaternal GM (ab/
abb) which was “transmitted” to her healthy mosaic
daughter (bc/bbc) and to her son (bc/bbc) who gave
birth to their offspring with non mosaic trisomy (bcd
and bbe, respectively).
Summarizing, among 80 families, at least 12 families
displaying mosaicism for T21 in successive generations
were reported. There is most probably a bias towards
publication of such cases. Higher numbers of families
with trisomy 21 recurrence are needed for final evalua-
tion of this phenomenon. Irrespective of the mechan-
isms of the mosaicism “transmission”, this observation if
confirmed in future studies, would indicate the rele-
vance of cytogenetic testing of the unaffected offspring
of GM carrier for the presence of mosaicism.
Sex ratio in carriers of gonadal mosaicism
Whatever mechanism accounts for the loss of an extra
chromosome 21 from a trisomic conceptus, the remark-
able feature of GM carriers is the female prevalence.
There is a four-fold female preponderance in two
unbiased epidemiological studies in which parental
transmission of the extra chromosome was reported (16
maternally transmitted and four paternally transmitted
trisomy 21 cases) [33,44]. The proportion of female car-
riers of GM in this study (61 females and 19 males) is
somewhat lower, probably because of a bias towards
publishing “more interesting” cases of rare paternal
transmission. Since corresponding impairment of sper-
matogenesis was not documented for carriers of GM for
T21, some mechanisms other than reduced fertility in
male carriers might be involved. Recent studies suggest
that females may have GM for aneuploidy more often
than males due to sex-specific chromosome loss in early
embryogenesis [38].
Sex ratio in affected offspring
A male excess in Down syndrome patients with non-
mosaic T21 is a well known but poorly understood phe-
nomenon. The sex ratio in this group varies in different
populations, the average being close to 1.3. A meta-
analysis of data from epidemiological studies suggests
that the phenomenon is not restricted to free trisomy
21 alone but also appears in translocation T21, in car-
riers of mutant or inherited unbalanced translocations
[15]. Several mechanisms were proposed to explain the
skewed sex ratio in DS: meiotic disturbance (non-homo-
logous co-orientation in male meiosis), fertilization
event (greater accessibility of Y-bearing sperm to ova
disomic for chromosome 21), and post-fertilization
events (intrauterine selection against females).
Non-homologous co-orientation of the chromosome
21 and the X chromosome in male meiosis which was
proposed as a meiotic mechanism of joint segregation of
the chromosome 21 and the Y-chromosome [12,13,15]
still needs more supporting data. Besides, this mechan-
ism can only explain the male prevalence in T21 of
paternal origin which constitutes a minor part of all T21
cases [45]. Data from the present study indicate that
meiotic events may not be responsible for the skewed
sex ratio in DS since similar male preponderance was
found in both maternally- and paternally transmitted
T21.
Fertilization mechanisms suggest that Y-bearing sperm
can promote non-disjunction in the ova [15,16] or that
a disomic ovum can be more readily fertilized by Y-car-
rying sperm [14]. However, both these mechanisms are
not readily recognizable.
A comparison of the sex ratios in fetuses prenatally
diagnosed with DS and in live births with DS suggests
that there is no intrauterine selection favoring the survi-
val of males [17,18]. However, prenatally detected cases
represent a highly mixed group, including those referred
for advanced maternal ages, fetal serum markers, ultra-
sound abnormalities, parental anxiety, etc. As to GM
carriers, the predominant indication for prenatal testing
was “having a previous child with Down syndrome”.
The data presented in this paper suggest that a probable
explanation of the male prevalence in DS is an intrauterine
selection against female fetuses. Recent mFISH study
demonstrated a strong female prevalence among chromo-
somally abnormal miscarried fetuses [46]. According to
Kuo [47], the combined factors of embryonic quality and
endocrine dysfunction in female carriers of GM might
contribute to miscarriages that are very common to these
patients. Unfortunately the sample of both prenatally
detected and miscarried T21 offspring collected in the pre-
sent study is too small to allow a definitive conclusion on
the ability of mosaic mothers to carry affected fetuses to
term depending on the gender of the fetus. It should be
noted though that there is no significant male prevalence
in the unaffected offspring of female carriers of GM (18
males and 15 females, SR = 1.2).
Sex ratio in unaffected offspring
There is, however, a strong female excess among unaf-
fected offspring of male carriers of GM, with 3 males
and 11 females, the difference with unaffected offspring
of female carriers of GM is significant, p = 0.037.
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Although the sample is small one might speculate about
the genetic mechanism of such an unusual sex ratio. It
might be a non homologous co-orientation of two chro-
mosomes 21 with the X chromosome during the first
meiotic division in the trisomic spermatocyte that leads
to a preferential segregation of the X chromosome with
one chromosome 21 and, consequently, to an excess of
euploid females. However, a reciprocal strong excess of
males among offspring with paternally derived T21, due
to corresponding preferential segregation of the Y chro-
mosome with two chromosomes 21, has not been
observed. More families with paternal GM should be
analyzed to confirm (or reject) this suggestion. Studies
in sperm of male carriers might also contribute to
understanding meiotic behavior of both the extra chro-
mosome 21 and the sex chromosomes.
Maternal and grandmaternal ages
Maternal age is a well-established risk factor for non
mosaic regular T21. However although women of 35
years and older have an elevated risk of having trisomic
offspring, a comparatively low proportion of all DS
births occurs to these women. Approximately 60% of all
DS cases are born to young parents [48]. The underlying
mechanism is still unclear, but parental germ-line
mosaicism is one likely factor.
Analysis of publications reporting maternal age com-
position worldwide from 1970 to 1995 showed that in
most of them the mean maternal age in DS mothers
was reported to be higher than 30, fluctuating from 29.5
in Taiwan to 35.6 in Libya. In the majority of that
reports, mean population maternal age did not exceed
27, varying from 24.4 in Northeast Brasil to 28.1 year in
Libya [16]. In the present study, the majority of mothers
were young at the time of birth/conception of their first
offspring with Down syndrome; the average maternal
age was 26.4 years old which is similar to the average
maternal age in the general population. One may argue
that the mother’s age, being the “age at first born DS
child or fetus” could be biased lower as compared to
average age of mothers in the population. However the
figure of 26.4 is considerably lower compared to average
age in DS mothers ascertained because of having first
DS child. In the collected sample, there are 51 cases for
which a sufficient reproductive history and pregnancy
outcome were known. Of them, in 17 cases the first
born DS child was not the first born child. In this
group, the proportion of mothers aged 35 years or older
at the time of the DS birth was 6%, and the mean
maternal age was 28.4, which is still lower compared to
average age in DS mothers.
In agreement with previous reports [20,49], grandma-
ternal age at the time when carriers of GM were born
was significantly increased. This is consistent with the
assumption that the trisomic line occurred frequently as
a result of age-dependent meiotic error. GM carriers
born to young parents probably start as diploid zygote
followed by a mitotic NDJ. Postzygotic NDJ as a
mechanism of T21 formation was proven not to be
associated with advanced maternal age [50]. Unfortu-
nately, the lack of information on both grandmaternal
age and the nature of the trisomy in GM mosaicism car-
riers in the majority of the reported families did not
allow analysis of the association between maternal age
and the origin of trisomy in asymptomatic carriers of
gonadal mosaicism.
Materials and methods
The data for this study were obtained from an exten-
sive literature review. Only cases that presented infor-
mation sufficient to infer a high probability of true
parental GM, together with known sex of the affected
offspring, were included in the study. Because of the
rarity of published cases, every effort was made to
identify as many of the published cases as possible,
including cases published in abstract form. A few
cases were retrieved from log-books of St. Petersburg
Centre of Medical Genetics (SPCMG) and Leningrad
Region Medical Genetics Unit (LRMG). Whenever
possible, information on the parental ages at the DS
birth/conception and at the transmitting GM carrier’s
birth, as well as information on the sex of the unaf-
fected offspring, was retrieved from the reported
cases. Collected data were analyzed using binomial
test and Chi-square test with Yates correction.
Conclusion
Both direct (results of cytogenetic and molecular study of
the origin of trisomic line) and indirect (advanced grand-
maternal age on the side of GM carrier) evidences allow
to assume that significant proportion of the mosaic par-
ents had been conceived as trisomics. Female-specific
trisomy rescue and genetic predisposition to postzygotic
non-disjunction has been suggested as mechanisms of
formation of both somatic mosaicism and GM. Typical
male preponderance in affected nonmosaic offspring with
either maternally- or paternally transmitted trisomy 21,
indicates than meiotic events are not responsible for the
skewed sex ratio in DS. However a female excess among
unaffected offspring of male carriers of GM might be the
result of meiotic non homologous co-orientation of chro-
mosomes 21 and X in spermatogenesis.
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Additional file 1: Table S1. Details of families with maternal trisomy
21 gonadal mosaicism. Tabular data presenting indication for the
testing of the carrier for the presence of abnormal line, proportion of
trisomic cell line; method of germ mosaicism ascertainment, maternal
age at birth/conception of DS child/fetus, grandparental ages at birth of
the carrier, outcome of carrier’s pregnancies, and sex of both affected
and unaffected offspring of female carriers of gonadal mosaicism.
Additional file 2: Table S2. Detailes of families with paternal
trisomy 21 gonadal mosaicism. Tabular data presenting indication for
the testing of the carrier for the presence of abnormal line, proportion of
trisomic cell line; method of germ mosaicism ascertainment, maternal
age at birth/conception of DS child/fetus, grandparental ages at birth of
the carrier, outcome of carrier’s pregnancies, and sex of both affected
and unaffected offspring of male carriers of gonadal mosaicism.
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